Resources

The Food and Drug Administration (FDA) has approved albiglutide (Tanzeum, GlaxoSmithKline), a once-weekly injectable glucagonlike peptide 1 (GLP-1) receptor agonist to treat type 2 diabetes…. “Tanzeum is a new treatment option for the millions of Americans living with type 2 diabetes,” Curtis Rosebraugh, MD, MPH, director of the Office of …

A new study by a University of Miami (UM) researcher analyzed nearly three decades of data on the effect of chromium supplementation on blood sugars….

The effects of ACEIs and ARBs on multiple outcomes in type 2 diabetes patients…. 

A recent analysis of youth with type 1 or type 2 diabetes shows that the incidence of DKA continues to be high…. 

Inter-arm systolic blood pressure differences may be a sign of bad things to come….

Noninvasive methods for screening pediatric patients with type 1 diabetes for peripheral diabetic neuropathy (DN) have low sensitivity, according to a systematic review….

Results of a recent large epidemiological study suggest that it is amount of dietary calories from sugar that plays the most pivotal role in diabetes risk…. 

  In this special feature for our series on SGLT2 inhibitors, we are extremely pleased to present this comprehensive slide series from the WorldWIDE Initiative for Diabetes Education. In this subset of their series, the Role of the Kidneys is examined and the effects of SGLT2 inhibitors is explained….

Lipid abnormalities The two main lipid molecules in the plasma are triglycerides and cholesterol To make these lipid particles water-soluble, they are bound to phospholipids and lipoproteins in plasma Lipid measurements are best performed on a fasting sample. The following measurements can be done: Total cholesterol (TC) high levels are …

  In this week’s Homerun Slides collection, we go over some of the behavioral modification options that are available for helping patients change their lifestyle habits. In addition, we also review some of the medications available to help with weight control….